Search results
Combination therapy shows promise in subset of breast cancers
Medical Xpress· 1 day agoCombining two cancer drugs may be a promising treatment for advanced metastatic breast cancer,...
Lilly and subsidiary Point Biopharma accused of patent infringement of cancer drugs - Indianapolis...
Indianapolis Business Journal· 1 day agoEli Lilly and Co. and a biopharma company it bought last year are accused of infringing on the...
AstraZeneca Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer
Reuters via AOL· 1 day agoThe approval from the U.S. Food and Drug Administration came after a late stage trial showed that...
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
Zacks via Yahoo Finance· 4 hours agoUpdated data from a clinical study shows that treatment with Mustang Bio's (MBIO) experimental cell...
Radioactive drugs strike cancer with precision
Knowable Magazine via Yahoo News· 6 days agoThe Endocyte acquisition brought a PSMA-targeted agent that would prove to be a real game-changer — both for patients with certain difficult-to-treat...
AstraZeneca’s lung cancer drug approved by US FDA for combination chemotherapy treatment | Invezz
Invezz· 1 day agoAstraZeneca, the largest pharmaceutical group in Britain, announced that the U.S. Food and Drug...
Colorectal cancer: How Metformin could help slow cancer cell growth
Medical News Today· 4 days agoUsing several different techniques to analyze the drug’s effects on the cells’ RNA, they found that...
Rutherrin(R) Increases Efficacy of Immunotherapy Preclinically
Digital Journal· 7 hours agoImmunotherapy, the latest technology in the war on cancer, can come in various forms; including: checkpoint inhibitors, ...
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
Zacks· 13 hours agoFree Report) reported updated results from a cohort of an ongoing phase I/II study evaluating its lead clinical candidate MB-106 in patients with Waldenstrom macroglobulinemia (WM), a rare form ...
FDA approves MSD’s KEYTRUDA for advanced endometrial cancer
Pharmaceutical Technology via Yahoo Finance· 10 hours agoThe US Food and Drug Administration (FDA) has approved MSD’s anti-PD-1 therapy KEYTRUDA for use with...